F141L in PreS2 has been reported to be significantly related to HCC progression in Korean chronic patients by inducing cell cycle progression by downregulating the p53 and p21 pathways and upregulating CDK4 and cyclin A [28]. The gene discussed is CDK4; the disease is hepatocellular carcinoma.